120 related articles for article (PubMed ID: 37258312)
21. Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases.
Barbier CE; Garske-Román U; Sandström M; Nyman R; Granberg D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1425-31. PubMed ID: 26631239
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
23. Midgut Neuroendocrine Tumors with Liver-only Metastases: Benefit of Primary Tumor Resection.
Gangi A; Manguso N; Gong J; Crystal JS; Paski SC; Hendifar AE; Tuli R
Ann Surg Oncol; 2020 Oct; 27(11):4525-4532. PubMed ID: 32394299
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors.
Wonn SM; Limbach KE; Pommier SJ; Ratzlaff AN; Leon EJ; McCully BH; Pommier RF
Surgery; 2021 Jan; 169(1):168-174. PubMed ID: 32473829
[TBL] [Abstract][Full Text] [Related]
25. Lung Shunt Fraction prior to Yttrium-90 Radioembolization Predicts Survival in Patients with Neuroendocrine Liver Metastases: Single-Center Prospective Analysis.
Ludwig JM; Ambinder EM; Ghodadra A; Xing M; Prajapati HJ; Kim HS
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1007-14. PubMed ID: 26964779
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
28. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
29. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract][Full Text] [Related]
31. Quantitative Pretreatment CT Parameters as Predictors of Tumor Response of Neuroendocrine Tumor Liver Metastasis to Transcatheter Arterial Bland Embolization.
Liu Y; Chen W; Cui W; Liu H; Zhou X; Chen L; Li J; Chen M; Chen J; Wang Y
Neuroendocrinology; 2020; 110(7-8):697-704. PubMed ID: 31639795
[TBL] [Abstract][Full Text] [Related]
32. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
33. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
[TBL] [Abstract][Full Text] [Related]
34. Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer.
Sørensen SM; Høgdall C; Mosgaard BJ; Dalgaard MIR; Jensen MP; Fuglsang K; Schnack TH
Acta Obstet Gynecol Scand; 2022 Mar; 101(3):334-343. PubMed ID: 35187660
[TBL] [Abstract][Full Text] [Related]
35. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
Bian C; Yao K; Li L; Yi T; Zhao X
Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
[TBL] [Abstract][Full Text] [Related]
36. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
[TBL] [Abstract][Full Text] [Related]
38. Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
Bertani E; Fazio N; Radice D; Zardini C; Grana C; Bodei L; Funicelli L; Ferrari C; Spada F; Partelli S; Falconi M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):981-989. PubMed ID: 27613553
[TBL] [Abstract][Full Text] [Related]
39. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
[TBL] [Abstract][Full Text] [Related]
40. Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: a critical appraisal of 48 cases.
Saxena A; Chua TC; Bester L; Kokandi A; Morris DL
Ann Surg; 2010 May; 251(5):910-6. PubMed ID: 20395859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
